BAXTER HLTHCARE CORP FDA Approval ANDA 207266

ANDA 207266

BAXTER HLTHCARE CORP

FDA Drug Application

Application #207266

Application Sponsors

ANDA 207266BAXTER HLTHCARE CORP

Marketing Status

Prescription001

Application Products

001INJECTABLE;SPINAL0.75%0BUPIVACAINE HYDROCHLORIDEBUPIVACAINE HYDROCHLORIDE

FDA Submissions

UNKNOWN; ORIG1AP2016-07-25STANDARD

Submissions Property Types

ORIG1Null1

TE Codes

001PrescriptionAP

CDER Filings

BAXTER HLTHCARE CORP
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 207266
            [companyName] => BAXTER HLTHCARE CORP
            [docInserts] => ["",""]
            [products] => [{"drugName":"BUPIVACAINE HYDROCHLORIDE","activeIngredients":"BUPIVACAINE HYDROCHLORIDE","strength":"0.75%","dosageForm":"INJECTABLE;SPINAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"07\/25\/2016","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2016-07-25
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.